Etiometry
119 Braintree Street
Suite 210
Allston
Massachusetts
02134
United States
Tel: 857-366-9333
Website: http://www.etiometry.com/
Email: info@etiometry.com
About Etiometry
Etiometry was founded in 2010 and is focused on providing next-generation clinical decision support software. The Etiometry Platform provides ICUs with actionable information through data consolidation, enhanced visualization and predictive analytics. It enables more informed decision making, improved patient care quality and decreased cost.YEAR FOUNDED:
2010
LEADERSHIP:
Founder and CEO: Evan Butler
Founder and CTO: Dimitar Baronov
Founder and CMO: Jesse Lock
CFO: Peter Rock
JOBS:
Please click here for Etiometry job opportunities.
FOLLOW ETIOMETRY:
Tweets by Etiometry
12 articles about Etiometry
-
Etiometry Gains FDA Clearance of AI-Based Algorithm that Alerts Risk of Hypercapnia for Neonates in Critical Care
8/1/2023
Etiometry, the leader in clinical decision-support software, announced its IVCO2 Index™ was cleared by the Food and Drug Administration for use with neonatal ICU patients under 2kg, who are especially vulnerable to the effects of hypercapnia.
-
Etiometry is the First to Achieve FDA Clearance of an AI-Based Risk Algorithm that Alerts for Inadequate Oxygenation of Adult Patients in Critical Care
1/24/2023
Etiometry , a leader in clinical decision-support software, announced today its IDO2 Index ™ was cleared for adult use by the Food and Drug Administration.
-
Etiometry's Clinical Decision-Support Software Receives CE Mark
10/12/2022
Etiometry , a leader in clinical decision-support software for critical care, announced today that the company has obtained the CE Mark under the European Union's medical device regulation, marking the second adult and third pediatric market authorization.
-
Etiometry Expands AI Software Platform Portfolio With 2 New FDA-Cleared Algorithms for Managing Critical Care Patients
7/12/2022
Etiometry , a leader in clinical decision-support software for critical care, announced today that it has doubled its FDA-cleared risk analytics portfolio to four indices, further strengthening its capability to track the fundamental pathways through which patients deteriorate under intensive care.
-
Radiometer and Etiometry Announce Partnership to Enhance Neonatal Intensive Care Clinical Workflows and Patient Outcomes
6/30/2022
Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, announced a new collaboration to enhance the clinical workflows in Neonatal Intensive Care Units.
-
Etiometry’s Platform for Clinical Decision Support Software Earns 6th FDA Clearance
12/2/2020
Etiometry’s Platform for Clinical Decision Support Software Earns 6 th FDA Clearance Newly cleared software updates based on feedback from platform’s clinician users
-
Latest Research Continues to Validate the Etiometry Platform’s Impact on Critical Care
3/18/2019
The American College of Cardiology Conference unveiled a first-of-its kind study evaluating the effect of a digital health platform based on registry data.
-
Etiometry Receives FDA 510(K) Clearance To Expand The Indications On Its IDO2 Index Powered By Risk Analytics
6/12/2017
-
Etiometry Brings Advanced Visualization And Analytics To The Hospital Bedside
2/23/2017
-
Etiometry Release: Company Reaches 10 Million Hours Of Patient Monitoring Data To Enhance ICU Patient Care
1/25/2017
-
Etiometry Co-Authors Award-Winning PCICS Abstract
12/12/2016
-
Etiometry Receives FDA 510(K) Clearance On Its First Algorithm, The IDO2 Index Powered By Risk Analytics For Neonates
10/4/2016